Literature DB >> 28481195

Prevalence of Fatty Liver Disease and Hepatic Iron Overload in a Northeastern German Population by Using Quantitative MR Imaging.

Jens-Peter Kühn1, Peter Meffert1, Christian Heske1, Marie-Luise Kromrey1, Carsten O Schmidt1, Birger Mensel1, Henry Völzke1, Markus M Lerch1, Diego Hernando1, Julia Mayerle1, Scott B Reeder1.   

Abstract

Purpose To quantify liver fat and liver iron content by measurement of confounder-corrected proton density fat fraction (PDFF) and R2* and to identify clinical associations for fatty liver disease and liver iron overload and their prevalence in a large-scale population-based study. Materials and Methods From 2008 to 2013, 2561 white participants (1336 women; median age, 52 years; 25th and 75th quartiles, 42 and 62 years) were prospectively recruited to the Study of Health in Pomerania (SHIP). Complex chemical shift-encoded magnetic resonance (MR) examination of the liver was performed, from which PDFF and R2* were assessed. On the basis of previous histopathologic calibration, participants were stratified according to their liver fat and iron content as follows: none (PDFF, ≤5.1%; R2*, ≤41.0 sec-1), mild (PDFF, >5.1%; R2*, >41 sec-1), moderate (PDFF, >14.1%; R2*, >62.5 sec-1), high (PDFF: >28.0%; R2*: >70.1 sec-1). Prevalence of fatty liver diseases and iron overload was calculated (weighted by probability of participation). Clinical associations were identified by using boosting for generalized linear models. Results Median PDFF was 3.9% (range, 0.6%-41.5%). Prevalence of fatty liver diseases was 42.2% (1082 of 2561 participants); mild, 28.5% (730 participants); moderate, 12.0% (307 participants); high content, 1.8% (45 participants). Median R2* was 34.4 sec-1 (range, 14.0-311.8 sec-1). Iron overload was observed in 17.4% (447 of 2561 participants; mild, 14.7% [376 participants]; moderate, 0.8% [20 participants]; high content, 2.0% [50 participants]). Liver fat content correlated with waist-to-height ratio, alanine transaminase, uric acid, serum triglycerides, and blood pressure. Liver iron content correlated with mean serum corpuscular hemoglobin, male sex, and age. Conclusion In a white German population, the prevalence of fatty liver diseases and liver iron overload is 42.2% (1082 of 2561) and 17.4% (447 of 2561). Whereas liver fat is associated with predictors related to the metabolic syndrome, liver iron content is mainly associated with mean serum corpuscular hemoglobin. © RSNA, 2017 Online supplemental material is available for this article.

Entities:  

Mesh:

Year:  2017        PMID: 28481195      PMCID: PMC5565690          DOI: 10.1148/radiol.2017161228

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  44 in total

1.  Fat quantification with IDEAL gradient echo imaging: correction of bias from T(1) and noise.

Authors:  Chia-Ying Liu; Charles A McKenzie; Huanzhou Yu; Jean H Brittain; Scott B Reeder
Journal:  Magn Reson Med       Date:  2007-08       Impact factor: 4.668

2.  Cohort profile: the study of health in Pomerania.

Authors:  Henry Völzke; Dietrich Alte; Carsten Oliver Schmidt; Dörte Radke; Roberto Lorbeer; Nele Friedrich; Nicole Aumann; Katharina Lau; Michael Piontek; Gabriele Born; Christoph Havemann; Till Ittermann; Sabine Schipf; Robin Haring; Sebastian E Baumeister; Henri Wallaschofski; Matthias Nauck; Stephanie Frick; Andreas Arnold; Michael Jünger; Julia Mayerle; Matthias Kraft; Markus M Lerch; Marcus Dörr; Thorsten Reffelmann; Klaus Empen; Stephan B Felix; Anne Obst; Beate Koch; Sven Gläser; Ralf Ewert; Ingo Fietze; Thomas Penzel; Martina Dören; Wolfgang Rathmann; Johannes Haerting; Mario Hannemann; Jürgen Röpcke; Ulf Schminke; Clemens Jürgens; Frank Tost; Rainer Rettig; Jan A Kors; Saskia Ungerer; Katrin Hegenscheid; Jens-Peter Kühn; Julia Kühn; Norbert Hosten; Ralf Puls; Jörg Henke; Oliver Gloger; Alexander Teumer; Georg Homuth; Uwe Völker; Christian Schwahn; Birte Holtfreter; Ines Polzer; Thomas Kohlmann; Hans J Grabe; Dieter Rosskopf; Heyo K Kroemer; Thomas Kocher; Reiner Biffar; Ulrich John; Wolfgang Hoffmann
Journal:  Int J Epidemiol       Date:  2010-02-18       Impact factor: 7.196

3.  Development, external validation, and comparative assessment of a new diagnostic score for hepatic steatosis.

Authors:  Peter J Meffert; Sebastian E Baumeister; Markus M Lerch; Julia Mayerle; Wolfgang Kratzer; Henry Völzke
Journal:  Am J Gastroenterol       Date:  2014-06-24       Impact factor: 10.864

4.  Prevalence of fatty liver in a general population of Okinawa, Japan.

Authors:  H Nomura; S Kashiwagi; J Hayashi; W Kajiyama; S Tani; M Goto
Journal:  Jpn J Med       Date:  1988-05

5.  R2* estimation using "in-phase" echoes in the presence of fat: the effects of complex spectrum of fat.

Authors:  Diego Hernando; Jens-Peter Kühn; Birger Mensel; Henry Völzke; Ralf Puls; Norbert Hosten; Scott B Reeder
Journal:  J Magn Reson Imaging       Date:  2012-10-10       Impact factor: 4.813

6.  Reproducibility of MRI-determined proton density fat fraction across two different MR scanner platforms.

Authors:  Geraldine H Kang; Irene Cruite; Masoud Shiehmorteza; Tanya Wolfson; Anthony C Gamst; Gavin Hamilton; Mark Bydder; Michael S Middleton; Claude B Sirlin
Journal:  J Magn Reson Imaging       Date:  2011-07-18       Impact factor: 4.813

7.  Serum iron levels and hepatic iron overload in nonalcoholic steatohepatitis and chronic viral hepatitis.

Authors:  Suleyman Uraz; Cem Aygun; Abdullah Sonsuz; Gulsen Ozbay
Journal:  Dig Dis Sci       Date:  2005-05       Impact factor: 3.199

8.  Magnetic resonance imaging and liver histology as biomarkers of hepatic steatosis in children with nonalcoholic fatty liver disease.

Authors:  Jeffrey B Schwimmer; Michael S Middleton; Cynthia Behling; Kimberly P Newton; Hannah I Awai; Melissa N Paiz; Jessica Lam; Jonathan C Hooker; Gavin Hamilton; John Fontanesi; Claude B Sirlin
Journal:  Hepatology       Date:  2015-02-05       Impact factor: 17.425

Review 9.  Fat and iron quantification in the liver: past, present, and future.

Authors:  Takeshi Yokoo; Jeffrey D Browning
Journal:  Top Magn Reson Imaging       Date:  2014-04

10.  T2* relaxometry in liver, pancreas, and spleen in a healthy cohort of one hundred twenty-nine subjects-correlation with age, gender, and serum ferritin.

Authors:  Nina F Schwenzer; Jürgen Machann; Michael M Haap; Petros Martirosian; Christina Schraml; Gerd Liebig; Norbert Stefan; Hans-Ulrich Häring; Claus D Claussen; Andreas Fritsche; Fritz Schick
Journal:  Invest Radiol       Date:  2008-12       Impact factor: 6.016

View more
  27 in total

1.  Dual-energy CT for liver iron quantification in patients with haematological disorders.

Authors:  Sebastian Werner; Bernhard Krauss; Ulrike Haberland; Malte Bongers; Uwe Starke; Tamam Bakchoul; Sigrid Enkel; Konstantin Nikolaou; Marius Horger
Journal:  Eur Radiol       Date:  2018-11-07       Impact factor: 5.315

2.  Feasibility and agreement of stiffness measurements using gradient-echo and spin-echo MR elastography sequences in unselected patients undergoing liver MRI.

Authors:  Guilherme Moura Cunha; Kevin J Glaser; Anke Bergman; Rodrigo P Luz; Eduardo H de Figueiredo; Flavia Paiva Proença Lobo Lopes
Journal:  Br J Radiol       Date:  2018-05-17       Impact factor: 3.039

3.  Effect of noise and estimator type on bias for analysis of liver proton density fat fraction.

Authors:  Edward M Lawrence; Nathan T Roberts; Diego Hernando; Lu Mao; Scott B Reeder
Journal:  Magn Reson Imaging       Date:  2020-10-02       Impact factor: 2.546

4.  Quantitative susceptibility mapping in combination with water-fat separation for simultaneous liver iron and fat fraction quantification.

Authors:  Huimin Lin; Hongjiang Wei; Naying He; Caixia Fu; Shu Cheng; Jun Shen; Baisong Wang; Xu Yan; Chunlei Liu; Fuhua Yan
Journal:  Eur Radiol       Date:  2018-02-22       Impact factor: 5.315

5.  Gender-specific liver aging and magnetic resonance imaging.

Authors:  Yì Xiáng J Wáng
Journal:  Quant Imaging Med Surg       Date:  2021-07

6.  Feasibility of balanced steady-state free precession sequence at 1.5T for the evaluation of hepatic steatosis in obese children and adolescents.

Authors:  Hong-Xi Zhang; Jun-Fen Fu; Can Lai; Feng-Yu Tian; Xiao-Li Su; Ke Huang
Journal:  Eur Radiol       Date:  2018-04-30       Impact factor: 5.315

7.  Modulation of Tetrachloroethylene-Associated Kidney Effects by Nonalcoholic Fatty Liver or Steatohepatitis in Male C57BL/6J Mice.

Authors:  Joseph A Cichocki; Yu-Syuan Luo; Shinji Furuya; Abhishek Venkatratnam; Kranti Konganti; Weihsueh A Chiu; David W Threadgill; Igor P Pogribny; Ivan Rusyn
Journal:  Toxicol Sci       Date:  2019-01-01       Impact factor: 4.849

8.  Simultaneous hepatic iron and fat quantification with dual-energy CT in a rabbit model of coexisting iron and fat.

Authors:  Yun Peng; Jing Ye; Chang Liu; Hongru Jia; Jun Sun; Jun Ling; Martin Prince; Chang Li; Xianfu Luo
Journal:  Quant Imaging Med Surg       Date:  2021-05

Review 9.  Non-alcoholic fatty liver diseases: current challenges and future directions.

Authors:  Elke Roeb
Journal:  Ann Transl Med       Date:  2021-04

10.  Contrasting recruitment of skin-associated adipose depots during cold challenge of mouse and human.

Authors:  Ildiko Kasza; Jens-Peter Kühn; Henry Völzke; Diego Hernando; Yaohui G Xu; John W Siebert; Angela L F Gibson; C-L Eric Yen; David W Nelson; Ormond A MacDougald; Nicole E Richardson; Dudley W Lamming; Philip A Kern; C M Alexander
Journal:  J Physiol       Date:  2021-04-15       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.